The Gaps — Healthcare Delivery

A "gap" in this analysis is the distance between the formal legal architecture of a healthcare-delivery program and the actual receipt it produces for a PA-3 constituent. Each sub-domain has its own gap analysis drawn from documented design features applied to documented PA-3 conditions. The patterns recur across sub-domains. D21's distinctive analytical contribution is that PA-3 healthcare delivery operates through a federal-entitlement-floor plus Pennsylvania-state-overlay plus dynamic-federal-policy-cycle architecture in which substantive delivery contributions and structural disruption mechanisms are simultaneously operative across multiple payer instruments, multiple institutional architectures, and multiple regulatory layers — producing distributional outcomes whose direction is documentable but whose magnitude is held open at the points of cumulative-mechanism interaction. The architecture is not coherent in the sense of being designed-as-a-system; it is the structural consequence of layered federal program design choices interacting with Pennsylvania's specific implementation choices (HealthChoices PH-MCO plus CHC-MCO dual managed-care; county-based BH-MCO carve-out; state-based-exchange Pennie; PA Insurance Department oversight) interacting with Philadelphia-specific institutional features (CBH single-MCO contracting; anchor institutional concentration at Penn Medicine / Temple Health / Jefferson Health / CHOP; safety-net infrastructure at Hahnemann-precedent-shaped FQHC plus PDPH clinical landscape) interacting with the 2025-2026 federal-policy-cycle architecture (IRA delivery-side; OBBBA Medicaid; EPTC expiration; 340B Rebate Pilot; Title X disruption; Medicare telehealth post-PHE; MHPAEA partial non-enforcement; six-dimensional anchor accountability framework).

The recurring patterns

Three cross-cutting threads operate at every D21 sub-domain — each tailored to that SD's substantive territory while thematically aligned at the domain level.

Thread A — Federal-floor plus state-overlay architecture (operative at all 7 SDs). The federal entitlement and regulatory floor — Medicare Title XVIII at SD1; Medicaid Title XIX at SD2; ACA at SD3; CMS Conditions of Participation plus ACGME plus IRC § 501(r) plus EMTALA plus HIPAA plus the Hospital Price Transparency Rule at SD4; HRSA § 330 plus 340B plus FTCA at SD5; MHPAEA plus SAMHSA plus DEA plus 988 at SD6; specialty service-line federal architecture at SD7 — operates with Pennsylvania state-administrative-overlay (PA Insurance Department at SD1 / SD3 / SD6; PA DHS OMAP at SD2; PA DOH licensure at SD4 / SD5; PA OMHSAS at SD6). At SD6 a structurally-distinctive Philadelphia city-level carve-out (DBHIDS / CBH single-MCO architecture) adds a third layer. The federal-state interface is asymmetric: federal authority dominates at program-design structural features; state and local authority operate at administrative and consumer-protection layers.

Thread B — Federal-policy-cycle disruption mechanism (varies by SD). Each sub-domain documents a substantively-distinct federal-policy-cycle disruption mechanism operative in 2025-2026. The IRA Medicare Drug Price Negotiation Program delivery-side operationalization at SD1 (10 Part D drugs effective January 1, 2026; $2,100 OOP cap; Round 2 effective January 1, 2027). OBBBA Sections 71107 / 71115 / 71117 / 71119 Medicaid delivery-side flow-through at SD2 (6-month redetermination December 2026; work requirements January 2027; provider-tax safe-harbor stepdown FY 2028-2032; MCO-tax tightening). The IRA Enhanced Premium Tax Credit December 31, 2025 expiration at SD3 (102% Pennie premium increase; 145,000+ cumulative cancellations; H.R. 1834 pending Senate). The six-dimensional anchor accountability framework completion via inheritance from D6 Synthesis Section 2 at SD4 (the framework completes here with healthcare delivery as the sixth and most heavily-regulated dimension). The 340B Rebate Model Pilot court vacatur (AHA v. Kennedy, D. Me., February 10, 2026) and HRSA RFI trajectory at SD5. The MHPAEA 2024 Final Rule Trump-administration partial non-enforcement at SD6 (Tri-Agency statement May 9-15, 2025; ERIC v. DOL/HHS/Treasury in abeyance). The convergence of six concurrent federal-policy-cycle mechanisms at SD7 (IIJA reauthorization September 30, 2026; 340B post-vacatur; Title X disruption; Medicare telehealth post-2027; OBBBA flow-through; MHPAEA non-enforcement). Thread B mechanisms operate concurrently and compound at SD5 (six concurrent mechanisms) and SD7 (six convergent mechanisms at the cross-cutting closure layer).

Thread C — Both/And designations plus cross-SD and cross-domain integration. Each sub-domain operationalizes the Both/And discipline at one or more multi-classification items. MC54 PRIMARY at SD1 (Medicare Advantage federal-administrative-vulnerability plus substantive coordination including D-SNP integration and one-way structural lock-in absent PA state guaranteed-issue Medigap return). MC60 PRIMARY at SD2 (substantive managed-care architecture plus structural OBBBA fiscal disruption). MC61 candidate at SD3 (substantive ACA architecture plus structural EPTC-expiration disruption). MC53 PRIMARY at SD4 (501(r) community-benefit substantive contribution plus revenue-cycle structural impact on PA-3 household financial security via medical-debt architecture). MC55 PRIMARY HOM at SD5 (substantive § 330 plus 340B plus sliding-fee architecture plus cumulative structural fiscal vulnerability — the 2nd confirmed-pending emergent-from-interaction HOM instance project-wide). MC56 at SD6 (CBH single-MCO substantive innovation plus structural concentration risk; MHPAEA Both/And at G21-SD6-02). MC57 / MC58 / MC59 candidates plus Telehealth Both/And at SD7 (forward MC62 candidate). Thread C also carries the cross-SD bidirectional integration and the cross-domain principal-anchor architecture (D6 / D7 / D8 / D9 / D10 / D11 / D12 / D13 / D24 cross-references operative).

Two hold-open-magnitude instances

D21 surfaces two hold-open-magnitude (HOM) instances that the synthesis preserves at-magnitude without closure-through-analytical-assertion.

HOM 1 — Commitment-vs-outcome 7th-instance candidate at G21-SD4-01 (anchor hospital community benefit). Multiple commitment-side mechanisms (501(r) FAP architecture; SEPA Regional CHNA collaboration with the 11 participating health systems; Penn's documented $100 million contribution to SDP environmental management coincident with the SDP AHERA enforcement period per D6 MC-03; the federal community-benefit reporting requirement framework with Form 990 Schedule H disclosures; the operative 2025 SEPA Regional CHNA implementation strategy frameworks) interact with multiple outcome-side mechanisms (medical-debt collection pressure on PA-3 households; only 30% of PA hospitals compliant with the Hospital Price Transparency Rule per independent audit; the HUP $182.7M / Temple $44.9M / Jefferson $2.5M / Hahnemann $32M PA medical-malpractice context with 2024 PA tort reform shortening certain windows to 18 months; revenue-cycle architecture impact at the household financial-security layer; the CFPB medical-debt rulemaking trajectory disrupted by the July 2025 Cornerstone Credit Union League v. CFPB E.D. Tex. vacatur). The relative magnitude of commitment-vs-outcome mechanisms cannot be ranked from the synthesis level without analytical closure that the evidence does not support. The HOM 7th-instance designation rests with lead direction at batch checkpoint review and Phase 3 verification empirical assessment.

HOM 2 — Emergent-from-interaction 2nd-instance candidate at G21-SD5-01 (FQHC + safety-net cumulative fiscal vulnerability) with within-shape sub-pattern variation. Six concurrent federal-policy-cycle mechanisms — OBBBA Sections 71115 / 71117 provider-tax safe-harbor stepdown (FY 2028-FY 2032 phase-down); OBBBA Section 71107 6-month Medicaid redetermination procedural-loss (effective December 2026); 340B Rebate Model Pilot disposition trajectory (court-vacated February 10, 2026; HRSA RFI closed April 20, 2026; H.R. 7391 bipartisan legislative protection); Community Health Center Fund reauthorization at the December 31, 2026 cliff ($4.6B FY 2026; chronic short-term extension pattern since 2019); OBBBA Section 71109 noncitizen Medicaid restrictions (effective October 1, 2026); Hahnemann-precedent institutional-fragility context — interact to produce PA-3 FQHC plus safety-net fiscal vulnerability. Median FQHC operating margins below negative 2% with less than 90 days cash on hand per NACHC. The within-shape sub-pattern variation distinguishes cumulative-impact-on-institutions at G21-SD5-01 (FQHCs and safety-net providers fiscally vulnerable) from cumulative-impact-on-individuals at D11 SD7 (children ending up in prison through interaction of independently-legitimate education, juvenile justice, welfare, and housing mechanisms). The relative analytical weight of sub-pattern variation is itself held open at magnitude pending methodology absorption queue evaluation.

Gaps by sub-domain

Each sub-domain's full gap analysis lives on its own page. Brief summaries below.

Sub-Domain 1 · Medicare Delivery Architecture

Approximately 2,981,142 Pennsylvania residents enrolled in Medicare for 2026; approximately 145,221 Philadelphia County MA enrollees (59.89% MA penetration); 66 Philadelphia County non-SNP MA plans plus 19 D-SNPs plus 7 I-SNPs; $2,100 Part D OOP cap in 2026; IRA Round 1 effective January 1, 2026. MC54 PRIMARY Both/And on Medicare Advantage federal-administrative-vulnerability plus substantive coordination — including the one-way structural lock-in created by federal MA enrollment-side flexibility plus Pennsylvania's underwriting-required Medigap return architecture (Co-Sponsorship Memo 47375 60-day birthday-rule window not enacted as of May 2026). Federal-rep leverage: federal guaranteed-issue Medigap return rights legislation; SHIP appropriation expansion; CMS oversight on MA capitation; IRA statutory protection. Sub-domain page →

Sub-Domain 2 · Medicaid Delivery Architecture

Approximately 658,000 Philadelphia County Medicaid-enrolled residents across the four-PH-MCO Southeast Zone (Aetna Better Health, Health Partners Plans, Keystone First, UnitedHealthcare Community Plan) plus CBH BH carve-out plus Community HealthChoices for dual-eligibles and LTSS. CHC 5-plan re-procurement pending. MC60 PRIMARY Both/And on OBBBA Sections 71107 / 71115 / 71117 / 71119 delivery-side flow-through: provider-tax safe-harbor stepdown from 6.0% to 3.5% by FY 2032; MCO-tax tightening effective July 4, 2025; 6-month redetermination effective December 2026; work requirements effective January 1, 2027. CMS implementation chronology through CMS Interim Final Rule due June 1, 2026. CBO projects 9.1 million Medicaid recipients affected by provider-tax provisions by FY 2034. Federal-rep leverage: OBBBA technical corrections; CMS implementation oversight; Rural Health Transformation Fund allocation. Sub-domain page →

Sub-Domain 3 · ACA Marketplace and Commercial Insurance Delivery

Pennie 2025 peak enrollment ~500,000; 2026 enrollment 452,525 as of May 1, 2026; 145,000+ cumulative cancellations; 102% average premium increase 2026; 85,000 OE 2026 terminations. H.R. 1834 House extension passed January 8, 2026 (230-196; 17 Republicans crossing including PA-1 Fitzpatrick, PA-7 Mackenzie, PA-8 Bresnahan); pending Senate. Senate CARE Act draft circulating but not advanced. December 2025 S. 3385 and S. 3386 failed cloture. PA Act 54 of 2024 affordability program enacted but unfunded. MC61 candidate Both/And. MHPAEA commercial enforcement gap (cross-reference SD6 G21-SD6-02). ERISA preemption gap at self-funded employer plans (the anchor-institution-employee paradox shared with D3 SD5). Federal-rep leverage: pending Senate H.R. 1834 action; OBBBA technical corrections; MHPAEA enforcement oversight. Sub-domain page →

Sub-Domain 4 · Hospital Institutional Architecture

PA-3 anchor hospital institutional architecture at Penn Medicine (HUP, Penn Presbyterian, Pennsylvania Hospital), Temple Health (Temple University Hospital, Episcopal), Jefferson Health (Thomas Jefferson University Hospitals, Einstein Medical Center post-2021, Jefferson Methodist), CHOP (3401 Civic Center Boulevard plus 50+ Care Network locations). Six-dimensional anchor accountability framework completion via inheritance from D6 (environmental + real estate + procurement + fiscal + employment + healthcare delivery). MC53 PRIMARY Both/And on community-benefit substantive contribution plus structural impact via revenue-cycle architecture. 7th confirmed-pending commitment-vs-outcome HOM instance project-wide. Only 30% of PA hospitals compliant with the federal Hospital Price Transparency Rule. Approximately 1 million Pennsylvanians carry medical debt; 83% with loads of $500+; nearly half paying $2,000+ per 2024 Commonwealth Fund. CFPB rule to remove all medical debt from credit reports vacated July 2025 in Cornerstone Credit Union League v. CFPB. PA medical-debt protections (PA Fair Credit Extension; wage-garnishment prohibition; credit-reporting prohibition; 4-year statute of limitations) operate as state-level mitigation. Federal-rep leverage: 501(r) framework amendments; Hospital Price Transparency Rule enforcement; No Surprises Act IDR rulemaking; Medicare GME / ACGME architecture. Sub-domain page →

Sub-Domain 5 · FQHC and Safety-Net Delivery

PA-3 FQHC architecture at Philadelphia FIGHT (Ryan White principal provider; 1233 Locust Street), Puentes de Salud (Latino community health; 1700 South Street), MANNA (medically tailored meals plus clinical; 420 N. 20th Street), Resources for Human Development (4700 Wissahickon Avenue), Family Practice & Counseling Network (1900 N. 9th Street); PDPH health center system. Section 330 community-board governance (51% patient board members), sliding-fee, FTCA, 340B, Medicaid PPS architecture. CHCF FY 2026 $4.6 billion via 2026 CAA — largest annual increase in a decade per NACHC — but expires December 31, 2026; not multi-year reauthorized since 2019. AHA v. Kennedy (D. Me., February 10, 2026) vacated 340B Rebate Model Pilot; HRSA RFI closed April 20, 2026 (5,576 comments). H.R. 7391 bipartisan with PA cosponsors Bresnahan (PA-8), Dean (PA-4), Smucker (PA-11). OBBBA Section 71109 noncitizen Medicaid restrictions effective October 1, 2026. MC55 PRIMARY HOM emergent-from-interaction shape — 2nd confirmed-pending project-wide; within-shape sub-pattern variation cumulative-impact-on-institutions. Median FQHC operating margins below negative 2% with less than 90 days cash on hand per NACHC. Hahnemann-precedent institutional fragility context. Federal-rep leverage: OBBBA technical corrections at each of the six mechanism trajectories simultaneously; H.R. 7391 cosponsorship/voting; CHCF multi-year reauthorization. Sub-domain page →

Sub-Domain 6 · Behavioral Health and SUD Delivery

Pennsylvania Behavioral HealthChoices county-based carve-out across 67 counties through 5 BH-MCOs with Community Behavioral Health exclusively in Philadelphia County; CBH operational since February 1997 as one of the first city-operated BH-MCOs in the U.S.; approximately 420,000 Philadelphia Medicaid recipients; 100,700+ active service users in 2023; $860M+ expenditures; CEO Donna E.M. Bailey, MSEd, MBA. CBH innovation: school-based BH since 2003; Evidence-based Practice and Innovation Center since 2013; CCBHC integration; D-SNP behavioral integration; CHC Team for senior 65+ and permanent-disability members. MC56 Both/And on single-MCO substantive innovation plus structural concentration risk. MHPAEA 2024 Final Rule Trump-administration partial non-enforcement (Tri-Agency statement May 9-15, 2025; ERIC v. DOL/HHS/Treasury in abeyance before Judge Timothy J. Kelly D.D.C.; case in abeyance May 12, 2025; non-enforcement until final decision plus 18 months; March 3, 2026 Tri-Agencies Fourth Report documents DOL "not as active as previously"). MHPAEA Both/And at G21-SD6-02. SAMHSA 42 C.F.R. Part 8 OTP Final Rule plus MAT Act DATA-Waiver elimination plus DEA-HHS permanent telemedicine flexibility plus PA Act 98 of 2022 audio-only telehealth collectively simplify office-based buprenorphine prescribing. Heavy cross-reference surface with D3 verified file. Federal-rep leverage: MHPAEA 2024 Final Rule reconsideration; SAMHSA appropriation; 988 funding; OBBBA Medicaid flow-through affecting CBH capitation. Sub-domain page →

Sub-Domain 7 · Specialty Clinical and Cross-Cutting Delivery

Convergence layer of six concurrent federal-policy-cycle mechanisms — IIJA reauthorization (P.L. 117-58 expires September 30, 2026; no reauthorization bill introduced as of May 2026; House T&I Committee 12+ hearings since 2025 with Rouzer R-NC and Larsen D-WA leading; BASICS Act H.R. 7437 Bresnahan PA-8 + McDonald Rivet D-MI; CRS R47573 projects $166-199 billion reauthorization gaps; HTF balance ~$45B end FY 2026); 340B Rebate Pilot post-vacatur (AHA v. Kennedy; HRSA RFI; H.R. 7391); Title X 2025-2026 administrative-disruption sequence (April 1, 2025 withholding plus December 2025 restoration plus March 13, 2026 HHS one-week guidance window plus April 1, 2026 OPA $261M continuation grants plus April 3, 2026 new guidelines plus FY 2027 zero funding signal plus March 16, 2026 128-Member letter); Medicare telehealth extension through December 31, 2027 under CAA 2026 plus CY 2026 PFS Final Rule permanent provisions; OBBBA Medicaid delivery-side flow-through; MHPAEA non-enforcement. MC57 / MC58 / MC59 candidate Both/And designations plus Telehealth Both/And at G21-SD7-04 (forward MC62 candidate). Three cross-domain principal-anchor deferrals from D13 (IIJA inflection plus Eastwick/Cobbs Creek cumulative-burden geography plus PA-state-fiscal-architectural asymmetry); secondary cross-references to D6, D2, D9, D10, D11, D24. Federal-rep leverage at five concurrent legislative-deadline trajectories simultaneously. Sub-domain page →

The aggregate finding

PA-3 healthcare delivery operates through a federal-entitlement-floor plus Pennsylvania-state-overlay plus dynamic-federal-policy-cycle architecture in which substantive delivery contributions and structural disruption mechanisms are simultaneously operative across multiple payer instruments, multiple institutional architectures, and multiple regulatory layers. The federal entitlement and regulatory floor provides substantive delivery capacity at scale — approximately 2,981,142 Pennsylvania residents in Medicare for 2026; approximately 658,000 Philadelphia County Medicaid residents; approximately 420,000 Philadelphia Medicaid recipients with BH coverage through CBH; approximately 9 million Part D enrollees nationally benefiting from IRA Round 1 first-year negotiated prices; the 2025 SEPA Regional CHNA architecture coordinating community-benefit planning across 11 PA-3-region anchor health systems; the federal MAT Act DATA-Waiver elimination plus DEA-HHS permanent telemedicine flexibility simplifying SUD treatment architecture. The Pennsylvania state-overlay operates with substantive contribution at the consumer protection layer (PA Medigap excess-charge prohibition; PA Insurance Department MA marketing oversight), the managed-care contracting layer (PA HealthChoices PH-MCO 4-plan Southeast Zone plus CHC-MCO 5-plan architecture), the licensure layer (PA DOH hospital and FQHC oversight), and the carve-out architecture (BH single-MCO assignment producing both substantive innovation and structural concentration risk at G21-SD6-01).

Simultaneously, the federal-policy-cycle architecture introduces structural disruption mechanisms operative across the same delivery instruments. OBBBA Sections 71107 plus 71109 plus 71115 plus 71117 plus 71119 flow through to PA-3 Medicaid delivery beginning October 2026 through January 2027 with multi-year compounding through FY 2032. The IRA Enhanced Premium Tax Credit December 31, 2025 expiration produced documented Pennie 102% premium increases and 145,000+ cumulative cancellations through May 1, 2026, with House-passed 3-year extension pending Senate action. The 340B Rebate Model Pilot court vacatur (AHA v. Kennedy, D. Me., February 10, 2026) and HRSA post-RFI rulemaking trajectory affect PA-3 anchor hospital pharmacy revenue at substantial scale. The Title X 2025-2026 administrative-disruption sequence affects Pennsylvania partial-Title-X-clinic exposure across multiple operational layers. The Medicare telehealth flexibility extension through December 31, 2027 creates a known reversion-risk inflection point at the post-2027 horizon. The MHPAEA 2024 Final Rule Trump-administration partial non-enforcement shifts federal parity enforcement architecture mid-cycle.

The substantive-and-structural simultaneity is operationalized through nine plus one operative architecture-level Both/Ands (MC53 PRIMARY at SD4; MC54 PRIMARY at SD1; MC55 PRIMARY HOM at SD5; MC56 at SD6; MC60 PRIMARY at SD2; MC61 candidate at SD3; MC57 / MC58 / MC59 candidates at SD7; MHPAEA Both/And at G21-SD6-02; Telehealth Both/And at G21-SD7-04 forward MC62). The Both/And discipline holds that the substantive delivery contribution and the structural disruption mechanism are both simultaneously operative; the disciplines that the synthesis cannot collapse to either-or and cannot close held-open magnitude through synthesis assertion. The two HOM instances (commitment-vs-outcome 7th-instance at G21-SD4-01; emergent-from-interaction 2nd-instance with within-shape sub-pattern variation at G21-SD5-01) preserve the disciplinary structure for analyzing this convergence at the project-wide level.

What follows from this

Three policy implications follow from the gap pattern.

The first is a question of which gaps are within reach of which actors. Federal House representation operates at multiple concurrent levers — pending Senate action on H.R. 1834 EPTC extension; OBBBA technical corrections (Sections 71107 / 71109 / 71115 / 71117 / 71119); CHCF multi-year reauthorization (NACHC-requested $5.8 billion / 3 years; December 31, 2026 cliff); H.R. 7391 340B Community Health Center Drug Pricing Protection Act (PA cosponsors Bresnahan, Dean, Smucker); MHPAEA enforcement oversight at DOL EBSA, HHS, and Treasury (with 2024 Final Rule reconsideration trajectory); Title X appropriation and statutory architecture (with FY 2027 appropriation cycle and potential 2019 Protect Life Rule reinstatement NPRM); Medicare telehealth permanent legislation (current extension expires December 31, 2027); IIJA reauthorization (September 30, 2026 expiration); Hospital Price Transparency Rule enforcement; No Surprises Act IDR rulemaking; Rural Health Transformation Fund allocation. Pennsylvania state-level engagement is the principal complementary locus at PA Medicaid PPS rate-setting, PA OMHSAS Behavioral HealthChoices contracting, PA Insurance Department MHPAEA enforcement and PA Mental Health Parity Act enforcement, PA Hospital and Healthsystem Association advocacy, PA Department of Health hospital licensure, PA Act 54 of 2024 affordability program funding, and PA Act 98 of 2022 telehealth implementation. Local Philadelphia engagement at DBHIDS / CBH contracting, PDPH operations, and Philadelphia DHS coordination operates at the third layer.

The second is a question of administrative infrastructure. The federal-policy-cycle architecture in 2025-2026 concentrates harm at the institutional-capacity interface in some places (SAMHSA capacity erosion per the D3 verified TC-06; CMS implementation guidance posture; HRSA 340B rulemaking trajectory; HHS Title X Project 2025 reorientation) and at the statutory-protection interface in others (IRA EPTC expiration was congressional inaction; OBBBA was congressional action). The convergence layer at SD7 plus the six-concurrent-mechanism cumulative architecture at SD5 means single-mechanism federal engagement reduces individual mechanism magnitude but does not address the cumulative-vulnerability outcome that emerges from interaction. The MC55 SD5 emergent-from-interaction HOM 2nd-instance shape diagnostic provides the disciplinary structure for analyzing this at the project-wide level. Investment in state-level substitute infrastructure (PA Insurance Department MHPAEA enforcement growth per the March 2026 Tri-Agencies report; PA Act 54 of 2024 affordability program funding; PA DOH safety-net hospital oversight) becomes structurally more important when federal partnership capacity is degraded.

The third is a question of accountability documentation. Several gaps documented here — PA-3 FQHC complete roster magnitude (HRSA-deemed plus look-alikes); aggregate annual patient volume; sub-area-disaggregated FQHC and PDPH clinic utilization; FY 2026 FQHC operating margin and days-cash-on-hand metrics; PA-3 FQHC 340B pharmacy revenue magnitude; PA-3 anchor hospital community-benefit per Form 990 Schedule H; Hospital Price Transparency Rule compliance status by individual PA-3 anchor; PA medical-debt-collection-lawsuit volume by hospital; PA-3 specific Medicaid sub-area-disaggregated enrollment; PA-3 OBBBA-affected magnitude; PA-3 Pennie sub-area-disaggregated enrollment; PA-3 dialysis center geographic distribution; PA-3 Title X clinic roster and patient volume; PA-3 OTP geographic distribution and office-based buprenorphine prescriber concentration; CBH service utilization at sub-area resolution — would be partially closed by routine public disclosure rather than program reform. Several structural inferences in this domain remain inferences rather than measured outcomes because the data needed to measure them at the PA-3 sub-area scale is not consistently published or accessible. The verified file's F-flag inventory catalogues the institutional-retrieval items the next verification cycle will address.